Q-Bank Breakdown: Platelet plug formation — Why Every Answer Choice Matters

You just opened a heme question that looks like “platelets do platelet things,” but the answer choices are all plausible because they’re describing different steps of primary vs secondary hemostasis. The trick is to map the vignette to the exact defect in the sequence—then use the distractors to reinforce what comes before and after that step.

Tag: Heme/Onc > Hemostasis & Coagulation

---

The Clinical Vignette (Q-bank style)

A 16-year-old girl presents with easy bruising and frequent epistaxis since childhood. She reports heavy menstrual bleeding. Physical exam shows scattered petechiae. Labs:

• Platelet count: normal
• PT: normal
• aPTT: normal
• Bleeding time (or platelet function assay): prolonged

Which of the following is the most likely mechanism responsible for her bleeding?

A. Decreased binding of platelets to exposed subendothelial collagen
B. Impaired platelet aggregation due to defective GPIIb/IIIa
C. Failure to convert fibrinogen to fibrin due to factor XIII deficiency
D. Reduced activation of factor X due to tissue factor deficiency
E. Inhibition of cyclooxygenase leading to decreased thromboxane A₂ synthesis

---

Step 1/2 Framework: Where Platelet Plug Formation Fits

Hemostasis happens in a predictable order:

Primary hemostasis (platelet plug)

1. Endothelial injury → exposes collagen and releases vWF
2. Platelet adhesion: platelet GPIb binds vWF bound to collagen
3. Platelet activation: shape change + granule release (ADP, Ca²⁺) + TXA₂ production
4. Platelet aggregation: GPIIb/IIIa binds fibrinogen to cross-link platelets → temporary plug

Secondary hemostasis (fibrin stabilization)

• Coagulation cascade generates thrombin (IIa) → converts fibrinogen → fibrin
• Factor XIII cross-links fibrin → stable clot

Board-style pattern recognition:

• Mucocutaneous bleeding (petechiae, epistaxis, menorrhagia) → usually primary hemostasis
• Deep tissue bleeding (hemarthroses, muscle hematomas) → usually secondary hemostasis

---

Correct Answer: A — Decreased binding of platelets to exposed subendothelial collagen

This is von Willebrand disease (vWD) until proven otherwise.

Why it fits

• Normal platelet count but abnormal platelet function
• Prolonged bleeding time / platelet function assay
• PT normal; aPTT can be normal or mildly prolonged
  • because vWF stabilizes factor VIII, so deficiency can reduce VIII and prolong aPTT

The actual mechanism

Platelet adhesion defect: impaired GPIb–vWF–collagen interaction.

💡

High-yield one-liner: vWF helps platelets stick (adhesion) and protects factor VIII.

---

Why Every Distractor Matters (and how to eliminate fast)

B — Impaired platelet aggregation due to defective GPIIb/IIIa

This describes Glanzmann thrombasthenia.

What would differ:

• Also mucocutaneous bleeding + ↑ bleeding time, normal PT/aPTT
• Key distinction is aggregation vs adhesion
  • GPIIb/IIIa is for aggregation (platelet-to-platelet) via fibrinogen bridging

Classic test clue (often tested):

• Absent platelet aggregation in response to ADP/epinephrine/collagen
• Normal ristocetin test (because adhesion via vWF is intact)

Memory hook:

• “IIb/IIIa = IIBridge” (binds fibrinogen to bridge platelets)

---

C — Failure to convert fibrinogen to fibrin due to factor XIII deficiency

This is a secondary hemostasis issue—and the option is also subtly wrong mechanistically.

• Thrombin (factor IIa) converts fibrinogen → fibrin
• Factor XIII cross-links fibrin (stabilizes the clot)

What factor XIII deficiency actually causes:

• Delayed re-bleeding and poor wound healing (clot forms but is unstable)
• PT and aPTT are often normal (XIII is downstream of those tests)

Why it’s wrong for this vignette:

• The symptoms are classic primary hemostasis (mucocutaneous, petechiae)

---

D — Reduced activation of factor X due to tissue factor deficiency

This points to impaired extrinsic pathway initiation—but clinically, “tissue factor deficiency” is not the classic exam entity for a bleeding diathesis.

High-yield correction:

• Tissue factor (III) activates VII, which activates X
• Extrinsic pathway problems → ↑ PT (warfarin effect, vitamin K deficiency early, factor VII deficiency)

Why it’s wrong here:

• The vignette has normal PT
• Symptoms point to platelet plug formation, not coag factors

---

E — Inhibition of cyclooxygenase leading to decreased thromboxane A₂ synthesis

This is aspirin/NSAID effect: impaired platelet activation (reduced TXA₂).

TXA₂ does:

• Vasoconstriction
• Promotes platelet activation/aggregation

Clues you’d expect if E were correct:

• Clear medication history (aspirin)
• Platelet count normal, PT/aPTT normal, bleeding time can be prolonged

Why it’s wrong here:

• The vignette suggests a lifelong bleeding tendency starting in childhood—more consistent with inherited platelet adhesion defect (vWD) than acquired COX inhibition

---

Quick Comparison Table (Primary Hemostasis Hits)

💡

Ristocetin test concept: it assesses vWF-mediated platelet agglutination via GPIb.

---

High-Yield USMLE Takeaways

• Primary hemostasis = platelet plug → mucocutaneous bleeding (petechiae, epistaxis, menorrhagia).
• vWF = adhesion + factor VIII stability.
• GPIb binds vWF (adhesion); GPIIb/IIIa binds fibrinogen (aggregation).
• Thrombin makes fibrin; factor XIII cross-links fibrin.
• PT tests extrinsic/common (VII, X, V, II, fibrinogen). aPTT tests intrinsic/common (XII, XI, IX, VIII, X, V, II, fibrinogen).

---

How to Approach Similar Q-Bank Questions (Fast Algorithm)

1. Bleeding pattern: mucocutaneous (platelet) vs deep tissue (coag factors)
2. Screening labs: PT/aPTT normal? think platelet function/vWD
3. Mechanism match:
   • Adhesion → vWF/GPIb
   • Aggregation → GPIIb/IIIa/fibrinogen
   • Activation → ADP/TXA₂

If you train yourself to label each answer choice as adhesion vs activation vs aggregation vs fibrin stabilization, the question stops being a guessing game and becomes a flowchart.